Evaluating Orally Administered Meloxicam-Loaded Polymeric Nanocapsules in Female Dogs: A Population Pharmacokinetic Modeling Study

<b>Background/Objectives</b>: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently administered prophylactically to mitigate postoperative pain; however, its utility is limited by characteristic NSAID-associated adverse...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Flávia Elizabete Guerra Teixeira, Graziela de Araújo Lock, Renata Giacomeli, Camila de Oliveira Pacheco, Tamara Ramos Maciel, Ana Pozzato Funghetto-Ribeiro, Gabriela Lugoch, Diego Vilibaldo Beckmann, Marília Teresa de Oliveira, Sandra Elisa Haas
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2026-03-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	NSAIDs dogs nanocapsules population pharmacokinetic modeling
Online-Zugang:	https://www.mdpi.com/1424-8247/19/3/412
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!